Rare Disease Pharma: Navigating the DOJ's Sponsored Testing Ruling
The Department of Justice (DOJ) recently made waves in the pharmaceutical industry with a ruling...
Unveiling New Insights in NSCLC with Large-Scale FISH Panel Data
The landscape of Non-Small Cell Lung Cancer (NSCLC) treatment is constantly evolving, with...